These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36057584)

  • 1. Nigerian stakeholders' perceptions of a pilot tier accreditation system for Patent and Proprietary Medicine Vendors to expand access to family planning services.
    OlaOlorun FM; Jain A; Olalere E; Daniel-Ebune E; Afolabi K; Okafor E; Dwyer SC; Ubuane O; Akomolafe TO; Baruwa S
    BMC Health Serv Res; 2022 Sep; 22(1):1119. PubMed ID: 36057584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of job aids in supporting task sharing family planning services to community pharmacists and patent proprietary medicine vendors in Kaduna and Lagos, Nigeria.
    Baruwa S; Tobey E; Okafor E; Afolabi K; Akomolafe TO; Ubuane I; Anyanti J; Jain A
    BMC Health Serv Res; 2022 Aug; 22(1):981. PubMed ID: 35915491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of patent and proprietary medicine vendors' associations in improving the quality of services in Nigeria's drug shops.
    Oyeyemi AS; Oladepo O; Adeyemi AO; Titiloye MA; Burnett SM; Apera I
    BMC Health Serv Res; 2020 Jun; 20(1):567. PubMed ID: 32571381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of patent and proprietary medicine vendors and communities of the tiered accreditation programme for family planning services in Lagos and Kaduna states, Nigeria.
    Igbokwe U; Baba-Ari AW; Igomu B; Okafor E; Musa I; Peters O; Okafor U; Molemodile Dele-Olowu S; Olalere E; Aigbogun E; Aina M
    Glob Public Health; 2023 Jan; 18(1):2230488. PubMed ID: 37417453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria.
    Chace Dwyer S; Jain A; Ishaku SM; Okunade FT; Uzomba C; Adebayo A; Tobey E
    BMC Public Health; 2019 Oct; 19(1):1362. PubMed ID: 31651273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and distribution of medicine vendors in 2 states in Nigeria: implications for scaling health workforce and family planning services.
    Daini BO; Okafor E; Baruwa S; Adeyanju O; Diallo R; Anyanti J
    Hum Resour Health; 2021 May; 19(1):60. PubMed ID: 33933081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in clients' perceptions of family planning quality of care in Kaduna and Lagos States, Nigeria: A mixed methods study.
    Akomolafe TO; OlaOlorun FM; Okafor E; Baruwa S; Afolabi K; Jain A
    Front Glob Womens Health; 2022; 3():1034966. PubMed ID: 36483089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Contraceptive Service Quality and Accessibility for Adolescents and Youth Through Proprietary Patent Medicine Vendors in Four Nigerian States.
    Akila D; Akinola O; Omotoso O; Ohkubo S; Adefila A; Yohanna P; Kalu NI; Oyeyemi A; Ojelade O; Waziri A; Kwaknat W; Solanke O; Emonena B; Rotimi O; Mwaikambo L; Igharo V; Ajijola L; Bose K
    Glob Health Sci Pract; 2024 May; 12(Suppl 2):. PubMed ID: 38508767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do fertility intentions lead to contraceptive continuation among a cohort of family planning users who received services from the private sector in Nigeria.
    Chace Dwyer S; Jain A; Baruwa S; Okafor E; Babajide Oluseyi D; Ubuane O
    Gates Open Res; 2021; 5():103. PubMed ID: 35677699
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of integrated community case management of childhood illness (ICCM) practices by trained patent and proprietary medicine vendors (PPMVs) in Ebonyi and Kaduna states, Nigeria.
    Oko AB; Jennifer A; Chinyere AJ; Nelson NJ; Omokhudu I; Edward OC; Dennis A
    BMC Health Serv Res; 2023 Jan; 23(1):57. PubMed ID: 36658517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social support in the practices of informal providers: The case of patent and proprietary medicine vendors in Nigeria.
    Sieverding M; Liu J; Beyeler N
    Soc Sci Med; 2015 Oct; 143():17-25. PubMed ID: 26331864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do changes in motivation to prevent pregnancy influence contraceptive continuation? Results from a longitudinal study with women who receive family planning services from Community Pharmacists and Patent and Proprietary Medicine Vendors in Nigeria.
    Chace Dwyer S; Baruwa S; Okafor E; Daini BO; Ubuane O; Jain A
    Reprod Health; 2022 Feb; 19(1):39. PubMed ID: 35135583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of nursing mothers' and young people's access to proprietary and patent medicine vendors' services in rural communities of south-eastern Nigeria: implication for review of national drug policy.
    Uneke CJ; Obeka I; Uneke BI; Umeokonkwo A; Nweze CA; Otubo KI; Uguru OE
    J Pharm Policy Pract; 2021 Nov; 14(Suppl 1):92. PubMed ID: 34784979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria testing and treatment knowledge among selected rural patent and proprietary medicine vendors (PPMV) in Nigeria.
    Oladepo O; Oyeyemi AS; Titiloye MA; Adeyemi AO; Burnett SM; Apera I; Oladunni O; Alliu M
    Malar J; 2019 Mar; 18(1):103. PubMed ID: 30917835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Government stakeholders' perspectives on the family planning environment in three Nigerian cities: qualitative findings from the Nigerian Urban Reproductive Health Initiative (NURHI) Sustainability Study.
    McGuire C; Calhoun LM; Mumuni T; Maytan-Joneydi A; Odeku M; Speizer IS
    Glob Health Action; 2020 Dec; 13(1):1847821. PubMed ID: 33373279
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review of the role of proprietary and patent medicine vendors in healthcare provision in Nigeria.
    Beyeler N; Liu J; Sieverding M
    PLoS One; 2015; 10(1):e0117165. PubMed ID: 25629900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of patent and proprietary medicine vendor provision of injectable contraceptives: preliminary results from implementation science research in Oyo and Nasarawa, Nigeria.
    Chace Dwyer S; Ishaku SM; Okunade F; Reichenbach L; Jain A
    Contraception; 2018 Nov; 98(5):460-462. PubMed ID: 30145127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of drug vendors in improving basic health-care services in Nigeria.
    Liu J; Prach LM; Treleaven E; Hansen M; Anyanti J; Jagha T; Seaman V; Ajumobi O; Isiguzo C
    Bull World Health Organ; 2016 Apr; 94(4):267-75. PubMed ID: 27034520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the adoption of a digital health service by patent proprietary medicine vendors (PPMVs) in Lagos, Nigeria.
    Agha S; Ruiz-Gaona LA; Friedman J; Cheikh N; Gorgens M
    Digit Health; 2022; 8():20552076221142666. PubMed ID: 36478986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Care-seeking at patent and proprietary medicine vendors in Nigeria.
    Prach LM; Treleaven E; Isiguzo C; Liu J
    BMC Health Serv Res; 2015 Jun; 15():231. PubMed ID: 26067426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.